Gen-Probe (GPRO) (REN) (RNR) (SLE) (CPNO) (FST) Upgraded

Gen-Probe Incorporated (NASDAQ: GPRO), Resolute Energy Corp. (NYSE: REN), RenaissanceRe Holdings Ltd. (NYSE: RNR), Sara Lee (NYSE: SLE), Copano Energy, L.L.C. (NASDAQ: CPNO) and Forest Oil Co. (NYSE: FST) were upgraded by analysts.

Resolute Energy Corp. (REN) was upgraded by Sterne Agee from an “Underperform” rating to a “Neutral” rating.

RenaissanceRe Holdings Ltd. (RNR) was upgraded by Wells Fargo & Co. (NYSE:WFC) from a “Market Perform” rating to an “Outperform” rating.

Sara Lee (SLE) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating. They have a price target of $20.00 on the company.

Copano Energy, L.L.C. (CPNO) was upgraded by Morgan Stanley (NYSE:MS) from an “Equal Weight” rating to an “Overweight” rating.

Forest Oil Co. (FST) was upgraded by Stifel Nicolaus from a “Hold” rating to a “Buy” rating. They have a price target of $20.00 on the company.

Gen-Probe Incorporated (GPRO) was upgraded by RBC Capital from a “Sector Perform” rating to an “Outperform” rating. They have a price target of $72.00 on the company, up from $53.00.

BlackRock (BLK) (AYR) (END) (CTBI) (DFT) (GPRO) Ratings, Price Targets

BlackRock, Inc. (NYSE: BLK), Aircastle Limited (NYSE: AYR), Endeavour International Co. (NYSE: END), Community Trust Bancorp, Inc. (NASDAQ: CTBI), DuPont Fabros Technology, Inc. (NYSE: DFT) and Gen-Probe Incorporated (NASDAQ: GPRO) ratings and price targets.

BlackRock, Inc. (BLK) had its “hold” rating reiterated by Jefferies Group (NYSE:JEF).

Aircastle Limited (AYR) is now covered by Morgan Stanley (NYSE:MS). They have an “equal weight” rating on the company.

Endeavour International Co. (END) had its price target lowered

by C.K. Cooper from $14.00 to $12.00. They have a “buy” rating on the company.

Community Trust Bancorp, Inc. (CTBI) was downgraded by Hilliard Lyons from a “buy” rating to a “neutral” rating.They have a price target of $31.00 on the company, up from $30.00.

DuPont Fabros Technology, Inc. (DFT) was downgraded by Macquarie from an “outperform” rating to a “neutral” rating.

Gen-Probe Incorporated (GPRO) was upgraded by RBC Capital from a “sector perform” rating to an “outperform” rating. They have a price target of $72.00 on the company, up from $53.00.

AGCO (AGCO) (DRIV) (FLS) (GDOT) (IPG) (GPRO) Price Targets Changed

AGCO Corp. (NASDAQ: AGCO), Digital River, Inc. (NASDAQ: DRIV), Flowserve Corp (NYSE: FLS), Green Dot Co. (NASDAQ: GDOT), Interpublic Group of Companies, Inc. (NYSE: IPG) and Gen-Probe Incorporated (NASDAQ: GPRO) price targets adjusted by analysts.

AGCO Corp. (AGCO) had its price target raised by UBS AG (NYSE:UBS) from $60.00 to $62.00. They have a “Buy” rating on the company.

Digital River, Inc. (DRIV) had its price target cut by RBC Capital from $40.00 to $36.00. They have an “Outperform” rating on the company.

Flowserve Corp. (FLS) had its price target slashed by RBC Capital from $145.00 to $130.00. They have an “Outperform” rating on the company.

Green Dot Co. (GDOT) had its price target lowered by JPMorgan Chase & Co. (NYSE:JPM) to $49.00.

Interpublic Group of Companies, Inc. (IPG) had its price target lowered by Goldman Sachs to $12.00. They have a “Neutral” rating on the company.

Gen-Probe Incorporated (GPRO) had its price target lowered by JPMorgan Chase & Co. to $64.00.

Ratings on (EXAC) (GPRO) (IHG) (JWN) (KSS) Reiterated by Analysts

Analysts reiterated their ratings on Exactech, Inc. (NASDAQ: EXAC), Gen-Probe Incorporated (NASDAQ: GPRO), Intercontinental Hotels Group (NYSE: IHG), Nordstrom, Inc. (NYSE: JWN) and Kohls Corp (NYSE: KSS) today.

Jefferies (NYSE:JEF) reiterated a “buy” rating on Exactech, Inc. (EXAC). They have a price target $9.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated an “overweight” rating on Gen-Probe Incorporated (GPRO).

Credit Suisse (NYSE:CS) reiterated an “outperform” rating on Intercontinental Hotels Group (IHG).

Goldman Sachs (NYSE:GS) reiterated a “buy” rating on Nordstrom, Inc. (JWN).

Goldman Sachs reiterated a “neutral” rating on Kohls Corp (KSS).

Ratings on (EXAC) (GPRO) (IHG) (JWN) (KSS) Reiterated by Analysts

Analysts reiterated their ratings on Exactech, Inc. (NASDAQ: EXAC), Gen-Probe Incorporated (NASDAQ: GPRO), Intercontinental Hotels Group (NYSE: IHG), Nordstrom, Inc. (NYSE: JWN) and Kohls Corp (NYSE: KSS) today.

Jefferies (NYSE:JEF) reiterated a “buy” rating on Exactech, Inc. (EXAC). They have a price target $9.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated an “overweight” rating on Gen-Probe Incorporated (GPRO).

Credit Suisse (NYSE:CS) reiterated an “outperform” rating on Intercontinental Hotels Group (IHG).

Goldman Sachs (NYSE:GS) reiterated a “buy” rating on Nordstrom, Inc. (JWN).

Goldman Sachs reiterated a “neutral” rating on Kohls Corp (KSS).

Price Targets on (DISH) (GPRO) (HMIN) (HOLX) (HUM) Updated

Price targets on DISH (NASDAQ: DISH), Gen-Probe Incorporated (NASDAQ: GPRO), Home Inns & Hotels Management Inc. (NASDAQ: HMIN), Hologic, Inc. (NASDAQ: HOLX) and Humana (NYSE: HUM) were updated today by analysts.

Kaufman Brothers raised their price target on DISH (DISH) from $31.00 to $36.00. They have a “buy” rating on the company.

RBC Capital raised their price target on Gen-Probe Incorporated (GPRO) from $57.00 to $90.00. They have a “sector perform” rating on the company.

Oppenheimer raised their price target on Home Inns & Hotels Management Inc. (HMIN) from $42.00 to $48.00. They have an “outperform” rating on the company.

Citigroup (NYSE:C) raised their price target on Hologic, Inc. (HOLX) from $24.00 to $26.00. They have a “buy” rating on the company.

Oppenheimer raised their price target on Humana (HUM) from $62.00 to $83.00. They have a “perform” rating on the company.

Price Targets on (GPRO) (GWR) (HERO) (HHS) (HLS) Updated

Price targets on Gen-Probe Incorporated (NASDAQ: GPRO), Genesee & Wyoming Inc. (NYSE: GWR), Hercules Offshore, Inc. (NASDAQ: HERO), Harte-Hanks, Inc. (NYSE: HHS) and HealthSouth (NYSE: HLS) were updated today.

Jefferies (NYSE:JEF) raised their price target on Gen-Probe Incorporated (GPRO) from $75.00 to $92.00. They have a “buy” rating on the company.

Jefferies raised their price target on Genesee & Wyoming Inc. (GWR) from $54.00 to $64.00. They have a “neutral” rating on the company.

Global Hunter Securities raised their price target on Hercules Offshore, Inc. (HERO) from $7.00 to $7.50.

JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Harte-Hanks, Inc. (HHS) from $15.00 to $11.00. They have a “neutral” rating on the company.

Jefferies raised their price target on HealthSouth (HLS) to $30.00.

Ratings of (RGC) (OSK) (RIMM) (RTIX) (GPRO) Downgraded

Analysts downgraded ratings of Regal Entertainment (NYSE: RGC), Oshkosh Truck (NYSE: OSK), Research In Motion (NASDAQ: RIMM), RTI Biologics Inc. (NASDAQ: RTIX) and Gen-Probe Incorporated (NASDAQ: GPRO) today.

Piper Jaffray downgraded Gen-Probe Incorporated (GPRO) from an “overweight” rating to a “neutral” rating. They have a price target of $78.00 on the company.

Robert W. Baird downgraded Oshkosh Truck (OSK) from an “outperform” rating to a “neutral” rating. They have a price target of $34.00 on the company, down from $47.00.

Raymond James (NYSE:RJF) downgraded Regal Entertainment (RGC) from a “buy” rating to an “outperform” rating.

Gleacher & Co. downgraded Research In Motion (RIMM) from a “buy” rating to a “neutral” rating.

The Benchmark Company downgraded shares of RTI Biologics Inc. (RTIX) from a “buy” rating to a “hold” rating. They have a price target of $3.00 on the company.

Ratings of (IM) (GPRO) (NTCT) (OSK) (RCL) Downgraded

Analysts downgraded ratings of Ingram Micro Inc. (NYSE: IM), Gen-Probe Incorporated (NASDAQ: GPRO), NetScout Systems, Inc. (NASDAQ: NTCT), Oshkosh Truck (NYSE: OSK) and Royal Caribbean Cruises Ltd. (NYSE: RCL) today.

Brean Murray downgraded Ingram Micro Inc. (IM) from a “buy” rating to a “hold” rating.

Canaccord Genuity downgraded Gen-Probe Incorporated (GPRO) from a “buy” rating to a “hold” rating. They have a price target of $88.00 on the company.

Wunderlich downgraded NetScout Systems, Inc. (NTCT) from a “buy” rating to a “hold” rating. They have a price target of $26.00 on the company, down from $28.00.

The Benchmark Company downgraded Oshkosh Truck (OSK) from a “buy” rating to a “hold” rating. They have a price target of $35.00 on the company, down from $45.00.

Raymond James (NYSE:RJF) downgraded Royal Caribbean Cruises Ltd. (RCL) from a “buy” rating to an “outperform” rating.

Ratings of (GPRO) (IM) (MEOH) (IMAX) (INFN) Downgraded

Analysts downgraded ratings of Gen-Probe Incorporated (NASDAQ: GPRO), Ingram Micro Inc. (NYSE: IM), Methanex Corporation (NASDAQ: MEOH), Imax Corporation (NASDAQ: IMAX) and Infinera Corp. (NASDAQ: INFN) today.

William Blair downgraded Gen-Probe Incorporated (GPRO) to a “market perform” rating.

Stifel Nicolaus downgraded Ingram Micro Inc. (IM) from a “buy” rating to a “hold” rating.

UBS AG (NYSE:UBS) downgraded Methanex Corporation (MEOH) from a “buy” rating to a “neutral” rating.

Canaccord Genuity downgraded Imax Corporation (IMAX) from a “buy” rating to a “hold” rating.

JPMorgan Chase & Co. (NYSE:JPM) downgraded Infinera Corp. (INFN) to an “underweight” rating.

Ratings of (DAL) (ENDP) (FLEX) (GPRO) (HP) Downgraded

Analysts downgraded ratings of Delta Air Lines (NYSE: DAL), Endo Pharmaceuticals (NASDAQ: ENDP), Flextronics International Ltd. (NASDAQ: FLEX), Gen-Probe Incorporated (NASDAQ: GPRO) and Helmerich & Payne (NYSE: HP) today.

Capstone downgraded Delta Air Lines (DAL) from a “hold” rating to a “sell” rating.

Duncan Williams downgraded Endo Pharmaceuticals (ENDP) to a “buy” rating. They have a price target of $51.00 on the company.

Argus analysts downgraded Flextronics International Ltd. (FLEX) from a “buy” rating to a “hold” rating.

Gleacher & Co. downgraded Gen-Probe Incorporated (GPRO) from a “buy” rating to a “neutral” rating.

Canaccord Genuity downgraded Helmerich & Payne (HP) from a “buy” rating to a “hold” rating.

B&G (BGS) (X) (BWLD) (ENP) (GPRO) Get Ratings Downgrades

B&G Foods, Inc. (NYSE: BGS), U.S. Steel (NYSE: X), Buffalo Wild Wings (NASDAQ: BWLD), Encore Energy Partners (NYSE: ENP) and Gen-Probe Incorporated (NASDAQ: GPRO) all got downgraded today.

Longbow Research downgraded B&G Foods, Inc. (BGS) from a “Buy” rating to a “Neutral” rating.

Goldman Sachs (NYSE:GS) downgraded U.S. Steel (X) from a “Buy” rating to a “Neutral” rating. They have a price target of $56 on the company, down from $74.00.

Raymond James (NYSE:RJF) downgraded Buffalo Wild Wings (BWLD) from a “Buy” rating to an “Outperform” rating.

Robert W. Baird downgraded Encore Energy Partners (ENP) from an “Outperform” rating to a “Neutral” rating. They placed a price target of $25 on the stock.

Madison Williams downgraded Gen-Probe Incorporated (GPRO) from a “Buy” rating to an “Accumulate” rating.

Gen-Probe (NASDAQ:GPRO) Appears Undervalued

Following their recent investor day where they reviewed their various business, Gen-Probe (NASDAQ:GPRO) appeared to be undervalued in the opinion of Canaccord.

Canaccord said, "We reiterate our BUY on Gen-Probe following its annual investor meeting yesterday, where it reviewed its current businesses, high value pipeline, and its corporate strategy, all of which we believe are undervalued. Revenue growth outlook for 2011 is high-single-digits."

Canaccord Genuity maintains a "Buy" rating on Gen-Probe, which closed Friday at $58.22, up $0.16, or 0.28 percent. They have a price target on them of $65.

Gen-Probe (NASDAQ:GPRO) Could Return to MDx Prominence

Citing soon to come commercialization of new platforms and tests, Jefferies said Gen-Probe (NASDAQ:GPRO) may return to prominence in the MDx group.

Jefferies stated, "GPRO is a cornerstone MDx co. providing infectious disease, blood screening, and other assays. Given the upcoming commercialization of new platforms and tests, recent acquisitions, and continued execution in STD detection and amplified blood screening, we believe GPRO can return to prominence in the MDx group."

Even so, Jefferies lowered their EPS estimate for full year 2011 from $2.45 to $2.42, and for full year 2012 announced its earnings estimate, which is $2.80 a share.

Full year revenue estimates for 2011 were dropped from $596.9 million to $592.8 million. For 2012 the revenue estimate is $648.9 million.

Jefferies maintains their "Buy" rating on Gen-Probe, which closed Tuesday at $51.86, gaining $0.22, or 0.43 percent. They have a price target of $60 on them, increasing it from $54.